RBP4 and hyperlipidemia: The most striking, novel finding of the present study is that RBP4 levels measured in childhood were strong predictors of the subsequent development of MS and each of its components (including IR, hyperglycemia, hypertension and hyperlipidemia) 10 years later, independent of obesity.